title: Influence of probiotics on Candida presence and IgA anti-Candida in the oral cavity.
abstract: Probiotics are defined as microorganisms that promote benefits to host health, mainly by regulating resident microbiota. Disequilibrium in microbiota can favor the growth of opportunist microorganisms and the development of pathologies, like candidosis caused by yeasts of the Candida genus. This work evaluated whether probiotics consumption was able to influence a specific immunological response to Candida and the presence of these yeasts in the oral cavity. Saliva samples were collected from healthy individuals and plated in Dextrose Saboraud Agar with chloramphenicol. Individuals presenting Candida in the oral cavity used the probiotic Yakult LB® for 20 days, after which new collections and identifications were performed. Anti-Candida IgA analysis was conducted using the ELISA technique. Analysis of the results showed a significant reduction in Candida prevalence (46%) and mean Candida CFU/mL counts (65%). The Candida species identified were C. albicans (98%) and C. tropicalis (2%), before and after probiotics consumption. Immunological analysis demonstrated a significant reduction in anti-Candida IgA levels after probiotics use, probably due to less antigenic stimulation. In conclusion, in the individuals studied, probiotics use significantly reduced the amount of Candida in the oral cavity, possibly due to competition between the yeasts rather than by specific secretory immune response stimulation.
authors.affiliation: Instituto Básico de Biociências, Universidade de Taubaté , Taubaté, SP , Brasil.
authors.forename: Agda Lima
authors.initials: AL
authors.lastname: Dos Santos
authors.forename: Antônio Olavo Cardoso
authors.initials: AO
authors.lastname: Jorge
authors.forename: Silvana Soléo Ferreira
authors.initials: SS
authors.lastname: Dos Santos
authors.forename: Célia Regina Gonçalves E
authors.initials: CR
authors.lastname: Silva
authors.forename: Mariella Vieira Pereira
authors.initials: MV
authors.lastname: Leão
keywords: Bifidobacterium; Candida; IgA; Lactobacillus casei
references.citation: Clin Exp Immunol. 1987 Nov;70(2):316-21
references.pmid: 3322616
references.citation: Infect Immun. 2004 Oct;72(10):5750-8
references.pmid: 15385474
references.citation: Appl Environ Microbiol. 1999 Nov;65(11):4949-56
references.pmid: 10543808
references.citation: Clin Exp Immunol. 2005 Jul;141(1):29-36
references.pmid: 15958067
references.citation: BMC Womens Health. 2008 Jan 15;8:3
references.pmid: 18197974
references.citation: BMJ. 2007 Jul 14;335(7610):80
references.pmid: 17604300
references.citation: Appl Environ Microbiol. 1996 Jun;62(6):1958-63
references.pmid: 8787394
references.citation: Rev Soc Bras Med Trop. 2005 Sep-Oct;38(5):383-6
references.pmid: 16172751
references.citation: Arch Oral Biol. 1982;27(8):617-21
references.pmid: 6753802
references.citation: J Dent Res. 2002 Jan;81(1):28-32
references.pmid: 11824413
references.citation: Folia Med (Plovdiv). 2002;44(4):39-44
references.pmid: 12751686
references.citation: J Dent Res. 2007 Feb;86(2):125-30
references.pmid: 17251510
references.citation: J Nutr. 2007 Mar;137(3 Suppl 2):798S-802S
references.pmid: 17311978
references.citation: Rev Iberoam Micol. 2003 Dec;20(4):160-3
references.pmid: 15456355
references.citation: Sex Transm Infect. 2004 Feb;80(1):48-53
references.pmid: 14755036
references.citation: J Appl Bacteriol. 1989 May;66(5):365-78
references.pmid: 2666378
references.citation: Clin Exp Allergy. 1998 Dec;28(12):1474-9
references.pmid: 10024217
references.citation: Int J Antimicrob Agents. 1999 Aug;12(4):287-92
references.pmid: 10493604
references.citation: Curr Opin Gastroenterol. 2007 Nov;23(6):679-92
references.pmid: 17906447